Skip to main content
. 2021 Nov 30;16(11):e0260384. doi: 10.1371/journal.pone.0260384

Table 3. Bacterial genera in patient and healthy groups.

Bacteria Patients Cases Controls Significance (P value) Odd Ratio
N (%) genera N (%) genera
Staphylococcus 25 (%10.5) 9(%5) ≤(0.001)* 11.6
Micrococcus 10 (%4.2) 16 (%8.8) NS1 0.438
Streptococcus 30 (%12.6) 30 (%16.5) NS 1
Enterococcus 10 (%4.2) 15 (%8.2) NS 0.5
Lactobacillus 16 (%6.9) 29 (%16.02) ≤(0.001)* 0.039
Fusobacterium 15 (%6.7) 2 (%1.1) ≤(0.001)* 9
Porphyromonas 16 (%6.9) 6 (%3.3) ≤(0.001)* 4.57
Bacteroides 29 (%11.8) 18 (%9.9) ≤(0.001)* 19.3
Prevotella 28 (%12) 16 (%8.8) ≤(0.001)* 12.25
Veillonella 4 (%1.7) 0 (%0) ≤(0.001)* 2.48
Actinomyces 23 (%9.7) 14 (%7.7) ≤(0.001)* 3.75
Propionibacterium 10 (%4.2) 3 (%1.6) ≤(0.001)* 4.5
Bifidobacterium 15 (%6.3) 8 (%4.4) NS 2.7
Peptostreptococcus 6 (%2.5) 15 (%8.2) ≤(0.001)* 0.250

* Significant, 1: Not Significant.